Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TELO Telomir Pharmaceuticals

交易中 01-22 15:36:56 EST

1.34

+0.02

+1.14%

最高1.36	最低1.32	成交量7.59万
今开1.32	昨收1.32	日振幅3.03%
总市值4,590万	流通市值2,046万	总股本3,438万
成交额10.16万	换手率0.50%	流通股本1,533万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":1.335,"timestamp":1769114029747,"preClose":1.32,"halted":0,"volume":75880,"delay":0,"changeRate":0.01136363636363629,"floatShares":15328300,"shares":34380971,"eps":-0.366519,"marketStatus":"交易中","change":0.015,"latestTime":"01-22 15:36:56 EST","open":1.32,"high":1.36,"low":1.32,"amount":101588.834508,"amplitude":0.030303,"askPrice":1.35,"askSize":270,"bidPrice":1.34,"bidSize":378,"shortable":3,"etf":0,"ttmEps":-0.366519,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1769115600000},"marketStatusCode":2,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":1.32,"preHourTrading":{"tag":"盘前","latestPrice":1.3197,"preClose":1.32,"latestTime":"09:27 EST","volume":2831,"amount":3708.8662055,"timestamp":1769092062369,"change":-0.0003,"changeRate":-0.000227,"amplitude":0.022727},"postHourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.32,"latestTime":"19:49 EST","volume":873,"amount":1160.57,"timestamp":1769042992387,"change":0.01,"changeRate":0.007576,"amplitude":0.007576},"volumeRatio":0.584711},"requestUrl":"/m/hq/s/TELO","defaultTab":"news","newsList":[{"id":"1112118530","title":"Telomir Pharmaceuticals：Telomir-1在侵袭性三阴性乳腺癌动物模型中显著抑制肿瘤生长与转移","url":"https://stock-news.laohu8.com/highlight/detail?id=1112118530","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112118530?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:08","pubTimestamp":1767618492,"startTime":"0","endTime":"0","summary":"在针对侵袭性三阴性乳腺癌的临床前研究中，Telomir Pharmaceuticals公司研发的候选药物Telomir-1展现出令人瞩目的抗肿瘤活性。实验数据显示，该药物能显著减缓肿瘤的生长速度，并有效抑制癌细胞的远端转移。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"1120352687","title":"Telomir Pharmaceuticals：Loi规定向Teli股东发行的Telomir股票需锁定6个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1120352687","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120352687?lang=zh_cn&edition=full","pubTime":"2025-10-21 06:08","pubTimestamp":1760998125,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals：Loi规定向Teli股东发行的Telomir股票需锁定6个月","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"1151299086","title":"Telomir Pharmaceuticals：10月17日签署意向书，通过股票置换收购Teli Pharmaceuticals所有股份 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1151299086","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151299086?lang=zh_cn&edition=full","pubTime":"2025-10-21 06:04","pubTimestamp":1760997848,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals：10月17日签署意向书，通过股票置换收购Teli Pharmaceuticals所有股份 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2576101702","title":"Telomir Pharmaceuticals, Inc.盘中异动 快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576101702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576101702?lang=zh_cn&edition=full","pubTime":"2025-10-17 00:28","pubTimestamp":1760632096,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日00时28分，Telomir Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.11%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101700281694cd591a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101700281694cd591a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1111836135","title":"Telomir Pharmaceuticals计划扩大研究范围至胰腺癌和白血病模型，并开展更多动物实验以提交IND申请——SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1111836135","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111836135?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:11","pubTimestamp":1759954274,"startTime":"0","endTime":"0","summary":"据SEC文件显示，Telomir Pharmaceuticals计划将研究范围扩展至胰腺癌和白血病模型，并将进行更多动物实验，为提交新药研究申请(IND)做准备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1184402809","title":"Telomir Pharmaceuticals：Telomir-1药物可选择性杀灭侵袭性三阴性乳腺癌细胞","url":"https://stock-news.laohu8.com/highlight/detail?id=1184402809","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184402809?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:06","pubTimestamp":1759953992,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals公司宣布，其研发的Telomir-1药物能够选择性杀灭侵袭性三阴性乳腺癌细胞，这一发现为治疗这种难治性癌症提供了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"1124222163","title":"Telomir Pharmaceuticals：Telomir-1药物可重置DNA甲基化并恢复肿瘤抑制因子功能——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124222163","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124222163?lang=zh_cn&edition=full","pubTime":"2025-10-07 04:06","pubTimestamp":1759781203,"startTime":"0","endTime":"0","summary":"根据SEC文件披露，Telomir Pharmaceuticals表示，其研发的Telomir-1药物能够重置DNA甲基化，从而恢复肿瘤抑制因子的功能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"1100700361","title":"Telomir Pharmaceuticals - 体外数据显示Telomir-1可靶向更多组蛋白去甲基化酶 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1100700361","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100700361?lang=zh_cn&edition=full","pubTime":"2025-09-18 19:36","pubTimestamp":1758195417,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals - 体外数据显示Telomir-1可靶向更多组蛋白去甲基化酶 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2558612842","title":"Telomir Pharmaceuticals, Inc.8月11日成交额为30.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558612842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558612842?lang=zh_cn&edition=full","pubTime":"2025-08-12 15:09","pubTimestamp":1754982564,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Telomir Pharmaceuticals, Inc.成交额为30.45万美元，成交额较昨日减少63.43%，当日成交量为19.33万股。Telomir Pharmaceuticals, Inc.于2025年8月11日涨1.28%，报1.58美元，该股过去5个交易日跌13.66%，年初至今跌61.65%，过去60日跌40.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|30.45万|-63.43%|19.33万|#|2025-08-08|83.28万|15.19%|51.51万|#|2025-08-07|72.30万|77.74%|42.68万|#|2025-08-06|40.68万|35.21%|22.35万|#|2025-08-05|30.09万|-36.84%|16.59万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812150927a6e11894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812150927a6e11894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2558585509","title":"Telomir Pharmaceuticals, Inc.8月8日成交额为83.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558585509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558585509?lang=zh_cn&edition=full","pubTime":"2025-08-09 15:09","pubTimestamp":1754723361,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Telomir Pharmaceuticals, Inc.成交额为83.28万美元，成交额较昨日增加15.19%，当日成交量为51.51万股。Telomir Pharmaceuticals, Inc.于2025年8月8日跌6.59%，报1.56美元，该股过去5个交易日跌11.36%，年初至今跌62.14%，过去60日跌43.27%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|83.28万|15.19%|51.51万|#|2025-08-07|72.30万|77.74%|42.68万|#|2025-08-06|40.68万|35.21%|22.35万|#|2025-08-05|30.09万|-36.84%|16.59万|#|2025-08-04|47.63万|-46.45%|26.47万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809150928a6dc3bde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809150928a6dc3bde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2556638038","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556638038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556638038?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:22","pubTimestamp":1754317332,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时22分，Telomir Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.11%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422221294ceffcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422221294ceffcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2556840031","title":"Telomir Pharmaceuticals, Inc.8月1日成交额为88.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556840031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556840031?lang=zh_cn&edition=full","pubTime":"2025-08-02 14:56","pubTimestamp":1754117815,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Telomir Pharmaceuticals, Inc.成交额为88.95万美元，成交额较昨日减少23.73%，当日成交量为49.03万股。Telomir Pharmaceuticals, Inc.于2025年8月1日跌5.88%，报1.76美元，该股过去5个交易日跌19.63%，年初至今跌57.28%，过去60日跌29.88%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|88.95万|-23.73%|49.03万|#|2025-07-31|116.63万|-46.16%|60.05万|#|2025-07-30|216.61万|36.61%|108.83万|#|2025-07-29|158.56万|6.35%|76.88万|#|2025-07-28|149.09万|-18.92%|70.17万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802145704a470f64e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802145704a470f64e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2556830294","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556830294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556830294?lang=zh_cn&edition=full","pubTime":"2025-08-01 02:13","pubTimestamp":1753985607,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日02时13分，Telomir Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.10%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.95%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021327a46e08d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021327a46e08d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2555201303","title":"Telomir Pharmaceuticals, Inc.7月29日成交额为158.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555201303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555201303?lang=zh_cn&edition=full","pubTime":"2025-07-30 15:13","pubTimestamp":1753859636,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Telomir Pharmaceuticals, Inc.成交额为158.56万美元，成交额较昨日增加6.35%，当日成交量为76.88万股。Telomir Pharmaceuticals, Inc.于2025年7月29日跌2.38%，报2.05美元，该股过去5个交易日跌2.38%，年初至今跌50.24%，过去60日跌18.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|158.56万|6.35%|76.88万|#|2025-07-28|149.09万|-18.92%|70.17万|#|2025-07-25|183.88万|-76.97%|82.16万|#|2025-07-24|798.27万|130.83%|341.56万|#|2025-07-23|345.82万|8.94%|167.86万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730151404a6c92f6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730151404a6c92f6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2555802709","title":"Telomir Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555802709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555802709?lang=zh_cn&edition=full","pubTime":"2025-07-29 03:43","pubTimestamp":1753731832,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时43分，Telomir Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.02%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290343539723c8a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290343539723c8a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2554715154","title":"Telomir Pharmaceuticals, Inc.7月25日成交额为183.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554715154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554715154?lang=zh_cn&edition=full","pubTime":"2025-07-26 14:58","pubTimestamp":1753513098,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Telomir Pharmaceuticals, Inc.成交额为183.88万美元，成交额较昨日减少76.97%，当日成交量为82.16万股。Telomir Pharmaceuticals, Inc.于2025年7月25日跌4.37%，报2.19美元，该股过去5个交易日跌3.95%，年初至今跌46.84%，过去60日跌13.44%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-25|183.88万|-76.97%|82.16万|#|2025-07-24|798.27万|130.83%|341.56万|#|2025-07-23|345.82万|8.94%|167.86万|#|2025-07-22|317.44万|-72.42%|150.11万|#|2025-07-21|1150.93万|-96.52%|537.47万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726145827a464680d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726145827a464680d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2554511537","title":"Telomir Pharmaceuticals, Inc.7月24日成交额为798.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554511537","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554511537?lang=zh_cn&edition=full","pubTime":"2025-07-25 14:43","pubTimestamp":1753425814,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，Telomir Pharmaceuticals, Inc.成交额为798.27万美元，成交额较昨日增加130.83%，当日成交量为341.56万股。Telomir Pharmaceuticals, Inc.于2025年7月24日涨11.17%，报2.29美元，该股过去5个交易日涨89.26%，年初至今跌44.42%，过去60日跌8.03%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-24|798.27万|130.83%|341.56万|#|2025-07-23|345.82万|8.94%|167.86万|#|2025-07-22|317.44万|-72.42%|150.11万|#|2025-07-21|1150.93万|-96.52%|537.47万|#|2025-07-18|3.30亿|834.06%|1.37亿|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725144345a462b4a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725144345a462b4a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2553271295","title":"Telomir Pharmaceuticals, Inc.7月23日成交额为345.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553271295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553271295?lang=zh_cn&edition=full","pubTime":"2025-07-24 14:41","pubTimestamp":1753339287,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Telomir Pharmaceuticals, Inc.成交额为345.82万美元，成交额较昨日增加8.94%，当日成交量为167.86万股。Telomir Pharmaceuticals, Inc.于2025年7月23日跌1.9%，报2.06美元，该股过去5个交易日涨79.13%，年初至今跌50.0%，过去60日跌19.22%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|345.82万|8.94%|167.86万|#|2025-07-22|317.44万|-72.42%|150.11万|#|2025-07-21|1150.93万|-96.52%|537.47万|#|2025-07-18|3.30亿|834.06%|1.37亿|#|2025-07-17|3536.36万|17527.17%|2970.20万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724144132a460a175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724144132a460a175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2552195444","title":"Telomir Pharmaceuticals, Inc.7月18日成交额为3.30亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552195444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552195444?lang=zh_cn&edition=full","pubTime":"2025-07-19 14:07","pubTimestamp":1752905245,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日，Telomir Pharmaceuticals, Inc.成交额为3.30亿美元，成交额较昨日增加834.06%，当日成交量为1.37亿股。Telomir Pharmaceuticals, Inc.于2025年7月18日涨88.43%，报2.28美元，该股过去5个交易日涨96.55%，年初至今跌44.66%，过去60日跌12.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-18|3.30亿|834.06%|1.37亿|#|2025-07-17|3536.36万|17527.17%|2970.20万|#|2025-07-16|20.06万|-56.95%|17.35万|#|2025-07-15|46.60万|169.46%|39.87万|#|2025-07-14|17.29万|-4.64%|14.81万|Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719140734a6b37a5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719140734a6b37a5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telomirpharma.com","stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.1081},{"period":"6month","weight":-0.3973},{"period":"1year","weight":-0.7323},{"period":"ytd","weight":-0.0075}],"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0203},{"period":"6month","weight":0.0758},{"period":"1year","weight":0.1366},{"period":"ytd","weight":0.0051}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Telomir Pharmaceuticals, Inc.于2021年8月成立为佛罗里达州的一家公司。该公司是一家临床前阶段制药公司，专注于TELOMIR-1的开发和商业化，TELOMIR-1是一种正在开发的新型小分子，可作为人类干细胞的口服原位治疗性治疗。原位干细胞疗法利用人体的自然资源来再生受损组织，并用新的功能性细胞取代细胞。","exchange":"NASDAQ","name":"Telomir Pharmaceuticals","nameEN":"Telomir Pharmaceuticals"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Telomir Pharmaceuticals,TELO,Telomir Pharmaceuticals股票,Telomir Pharmaceuticals股票老虎,Telomir Pharmaceuticals股票老虎国际,Telomir Pharmaceuticals行情,Telomir Pharmaceuticals股票行情,Telomir Pharmaceuticals股价,Telomir Pharmaceuticals股市,Telomir Pharmaceuticals股票价格,Telomir Pharmaceuticals股票交易,Telomir Pharmaceuticals股票购买,Telomir Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}